EDESA BIOTECH, INC. Current Federal Tax Expense (Benefit)
EDESA BIOTECH, INC. (EDSA) reported Current Federal Tax Expense (Benefit) of $0 for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-30.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2018-11-30
- EDESA BIOTECH, INC. current federal tax expense (benefit) for fiscal 2018 was $0.00.
- EDESA BIOTECH, INC. current federal tax expense (benefit) for fiscal 2017 was $0.00.
- EDESA BIOTECH, INC. current federal tax expense (benefit) for fiscal 2016 was $0.00.
- EDESA BIOTECH, INC. current federal tax expense (benefit) for fiscal 2015 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 1 month | Current Federal Tax Expense (Benefit) 12 month |
|---|---|---|
| 2018-09-30 | $0.00 10-K · filed 2018-11-30 | |
| 2017-09-30 | $0.00 10-K · filed 2018-11-30 | |
| 2016-09-30 | $0.00 10-K · filed 2017-12-01 | |
| 2015-09-30 | $0.00 10-K · filed 2017-12-01 | |
| 2014-09-30 | $0.00 10-K · filed 2016-12-14 | |
| 2014-08-31 | $0.00 10-K · filed 2016-12-14 | |
| 2013-08-31 | $0.00 10-K · filed 2014-11-21 | |
| 2012-08-31 | $0.00 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |